BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced that it has licensed its new patent pending PiP3™ technology to Rodan + Fields® Dermatologists, a leading clinical skincare brand by Stanford University-trained dermatologists Katie Rodan, M.D. and Kathy Fields, M.D.
